Fresh Tracks Therapeutics, Inc.
FRTX
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 73.02% | 60.33% | 42.75% | 59.96% | 46.54% |
| Total Depreciation and Amortization | 36.67% | 42.86% | 37.04% | 17.86% | 36.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.65% | -6.93% | -58.69% | -48.30% | -42.84% |
| Change in Net Operating Assets | -39.96% | 170.22% | 164.47% | 89.84% | 16.29% |
| Cash from Operations | 77.54% | 73.11% | 53.86% | 64.12% | 46.51% |
| Capital Expenditure | -- | 100.00% | -- | -1,275.00% | -30.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -1,275.00% | -30.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 432.77% | -43.18% | -58.98% | -65.18% | -96.26% |
| Repurchase of Common Stock | 30.91% | 90.57% | 100.00% | 100.00% | -7.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 454.41% | -42.74% | -58.75% | -65.02% | -96.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.02% | 107.60% | 44.28% | 62.70% | -463.42% |